* Core Laboratories NV CLB.N CLB is expected to show a
rise in
quarterly revenue when it reports results on April 27.
* The Amstelveen Noord-holland-based company is expected to
report a 9.6% increase in revenue to $118.817 million from
$108.38 million a year ago, according to the mean estimate from
6 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Core Laboratories
NV is
for earnings of 10 cents per share. For the same quarter last
year, the company reported earnings of 15 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $28, above its last closing price of $27.41.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.20 0.20 0.20 Met -0.4
Sep. 30 2021 0.18 0.19 0.18 Missed -3.8
Jun. 30 2021 0.19 0.19 0.18 Missed -6.2
Mar. 31 2021 0.12 0.13 0.15 Beat 15
Dec. 0.15 0.15 0.18 Beat 16.5
31 2020
Sep. 30 2020 0.13 0.15 0.16 Beat 9.2
Jun. 30 2020 0.10 0.10 0.14 Beat 42.1
Mar. 31 2020 0.31 0.34 0.31 Missed -7.5
This summary was machine generated April 26 at 02:10 GMT. All
figures in US dollars unless otherwise stated